IPP Bureau
Evonik sells Hanau pharma assets to ProChem in strategic portfolio shift
By IPP Bureau - June 21, 2026
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
Lubrizol and Polyhose launch advanced medical tubing plant in Chennai
By IPP Bureau - June 21, 2026
The new facility will produce precision extruded medical tubing used in minimally invasive medical devices
Univar expands EMEA reach in botanical ingredients push with American Distilling partnership
By IPP Bureau - June 21, 2026
The company will now distribute American Distilling’s range of natural specialty ingredients for use in cosmetics, personal care, and pharmaceutical applications across select EMEA markets
FDA expands use of Merck’s CAPVAXIVE for high-risk children and teens
By IPP Bureau - June 21, 2026
The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections
LabGenius and LG Chem strike AI-powered deal to develop next-gen tumour-targeting antibody therapy
By IPP Bureau - June 21, 2026
The collaboration is focused on overcoming a major limitation in existing cancer drugs
Zydus’s acquisition of Assertio to bolster its specialty pharma presence in US market
By IPP Bureau - June 20, 2026
Upon completion of the merger, Assertio will become a wholly owned subsidiary of Zydus Lifesciences and will be delisted from the Nasdaq
Alembic Pharma receives USFDA tentative approval for Binimetinib tablets
By IPP Bureau - June 20, 2026
Company becomes sole first applicant for 45 mg strength, positioning itself for potential 180-day generic exclusivity in the US market
Manipal Hospitals Mukundapur launches advanced Neuro Biplane Cathlab
By IPP Bureau - June 20, 2026
State-of-the-art facility brings next-generation imaging and minimally invasive neurointerventional capabilities to Eastern India
Automated cell therapy manufacturing attracts US$1.1 Billion across 34 funding rounds
By IPP Bureau - June 20, 2026
New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
Quadria-backed HealthQuad closes Rs. 550 crore first close for fund 3
By IPP Bureau - June 20, 2026
Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge
Govt pushes for identifying every missing TB case
By IPP Bureau - June 20, 2026
Over 28 crore people screened, TB incidence falls sharply as Centre urges states to intensify efforts ahead of July campaign deadline
Sameer Garaye promoted to Vice President at Hetero
By IPP Bureau - June 20, 2026
Seasoned pharmaceutical R&D leader takes on an expanded leadership role to drive innovation and strengthen Hetero’s advanced formulation development capabilities
AngioDynamics gets FDA nod for RELIEF trial to evaluate NanoKnife for enlarged prostate treatment
By IPP Bureau - June 19, 2026
Study will assess the safety and effectiveness of irreversible electroporation as a minimally invasive treatment option for benign prostatic hyperplasia (BPH)
Apollo Hospitals Seshadripuram expands cardiac care capacity with second Cath Lab
By IPP Bureau - June 19, 2026
New facility equipped with advanced imaging technology to support 200 additional procedures a month and benefit nearly 3,000 more patients annually
Brooks Instrument launches ultra-compact advanced mass flow controller for research applications
By IPP Bureau - June 19, 2026
New AMF Series combines industry-leading 1000:1 turndown capability, predictive diagnostics, and digital connectivity in a footprint no larger than a standard Post-it Note pad
